Cerclage Fixation of Third Fragment in Femoral Shaft Fracture is That Necessary
NCT07929428, Not applicable, Completed, Ain Shams University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Cerclage Fixation of Third Fragment in Femoral Shaft Fracture is That Necessary | ClinicalTrials.gov |
| NCT number | NCT07929428 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 42 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Ain Shams University | ClinicalTrials.gov |
| Conditions | Femoral Shaft Fracture | ClinicalTrials.gov |
| Interventions | Closed reduction and intramedullary nailing, Open reduction, cerclage fixation and intramedullary nailing | ClinicalTrials.gov |
| First posted | 2026-11-10 | ClinicalTrials.gov |
| Last updated | 2026-11-10 | ClinicalTrials.gov |
Registered outcomes 9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Radiographic union rate at six months | 6 months postoperatively | Proportion of patients with radiographic union, defined as bridging callus across at least three of four cortices on anteroposterior and lateral radiographs with painless full weight bearing, assessed using the Radiographic Union Score for Femur (RUSF) by two independent reviewers. | ClinicalTrials.gov |
| Secondary | Delayed union rate | 6 months postoperatively | Proportion of patients who failed to achieve radiographic union by six months. | ClinicalTrials.gov |
| Secondary | Nonunion rate | 9 months postoperatively | Proportion of patients who failed to achieve radiographic union by nine months | ClinicalTrials.gov |
| Secondary | Operative time | Intraoperative | Duration of surgery from skin incision to wound closure, in minutes. | ClinicalTrials.gov |
| Secondary | Intraoperative blood loss | Intraoperative | Estimated intraoperative blood loss, in millilitres. | ClinicalTrials.gov |
| Secondary | Postoperative complications | Up to 9 months postoperatively | Number of patients with postoperative complications, including surgical site infection. | ClinicalTrials.gov |
| Secondary | Discriminative ability of third-fragment projected area for delayed union | 9 months postoperatively | Third-fragment projected area (cm²), measured on preoperative imaging, evaluated for its ability to discriminate delayed union using receiver-operating-characteristic analysis, reported as the area under the curve (AUC). | ClinicalTrials.gov |
| Secondary | Discriminative ability of third-fragment length for nonunion | 9 months postoperatively | Third-fragment length (cm), measured on preoperative imaging, evaluated for its ability to discriminate nonunion using receiver-operating-characteristic analysis, reported as the area under the curve (AUC). | ClinicalTrials.gov |
| Secondary | Discriminative ability of third-fragment displacement for nonunion | 9 months postoperatively | Third-fragment displacement (mm), measured on preoperative imaging, evaluated for its ability to discriminate nonunion using receiver-operating-characteristic analysis, reported as the area under the curve (AUC). | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)